Patent · US Active

Combination of isoindolinone derivatives with SGI-110

US11236047B2 · kind B2 · utility

2Cited by
17References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 28, 2018
Grant dateFeb 1, 2022
Priority date
Expiry dateMar 28, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a combination comprising: Also provided are pharmaceutical compositions containing the combinations and medical uses of the combinations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.